Alternative Treatment for Diabetic Retinopathy
A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy (PDR), a complication of diabetes that damages blood vessels in the light-sensitive retina in the back of the eye. Lucentis is used to treat wet macular degeneration as well as diabetic macula edema. The study found the treatment no less effective than the laser therapy which currently is the standard treatment for PDR.
In a RPB-supported commentary, Timothy W. Olsen, MD, notes that "this important study [...] represents a major step forward for patients with PDR by providing the ophthalmologists who manage their retinal disease with new options." But he adds a cautionary note.
November 17, 2015
Related News: Diabetic Retinopathy, Top Story
New study shows that diabetic eye disease is up, but the most severe forms are down
Data from an RPB and MTMVI-supported study showed that while diabetes-related eye diseases doubled since 2014, the most severe forms of the disease have decreased.
RPB Hosts Vision Research Funding Partnership 2025
Leaders of organizations that fund vision research convened in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Research to Prevent Blindness Celebrates 65 Years of Success
Since 1960, RPB has been transforming vision research and eyecare for the benefit of all people
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2025 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Maria Bartolomeo Grant, MD, is recognized for ground-breaking contributions to the field of vision research.
The Time is Now to Protect the National Eye Institute
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
RPB Grantees Contribute to Eye Transplantation Effort
The ARPA-H THEA project takes on an exciting challenge.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2025 Research to Prevent Blindness. All Rights Reserved.
